Merlion Pharmaceuticals Pte
MerLion Pharmaceuticals Pte is dedicated to developing novel antibiotics to address the growing threat of bacterial infections in both humans and animals. The company primarily focuses on the antibiotic finafloxacin, which has shown significant promise in treating a variety of conditions, including acute otitis externa and complicated urinary tract infections.
With a commitment to combat infectious diseases caused by antibiotic-resistant bacteria, MerLion Pharmaceuticals is advancing its research in collaboration with organizations such as the UK Defence Science and Technology Laboratory. The company's innovative approach also includes medical countermeasures against potential biothreat agents, ensuring that finafloxacin is positioned as a key player in the field of biodefense.
Generated from the website
You might also like
Partial Data by Foursquare.